Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

EFTR

eFFECTOR Therapeutics (EFTR)

eFFECTOR Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EFTR
DatumZeitQuelleÜberschriftSymbolFirma
21/02/202423h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EFTReFFECTOR Therapeutics Inc
21/02/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EFTReFFECTOR Therapeutics Inc
10/02/202402h14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EFTReFFECTOR Therapeutics Inc
30/01/202414h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
26/01/202422h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
26/01/202422h32Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EFTReFFECTOR Therapeutics Inc
10/01/202414h06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
10/01/202414h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
08/01/202414h19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
08/01/202414h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
08/12/202314h31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
08/12/202314h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
28/11/202314h18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
28/11/202314h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
13/11/202322h25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EFTReFFECTOR Therapeutics Inc
13/11/202322h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
11/09/202322h58Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
11/09/202322h51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
08/08/202322h36Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EFTReFFECTOR Therapeutics Inc
08/08/202322h25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
08/08/202322h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EFTReFFECTOR Therapeutics Inc
08/08/202322h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
04/08/202322h06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
04/08/202322h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
04/08/202322h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
27/06/202312h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EFTReFFECTOR Therapeutics Inc
23/06/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EFTReFFECTOR Therapeutics Inc
08/06/202312h15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EFTReFFECTOR Therapeutics Inc
08/06/202312h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EFTReFFECTOR Therapeutics Inc
08/06/202312h07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:EFTReFFECTOR Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:EFTR